The British Journal of Cardiology

JULY 17, 2024

2–4 The studies will be well-known to nephrologists and demonstrated that angiotensin-receptor blockers (ARBs) had anti-proteinuric effects and/or slowed the decline of kidney function in patients with diabetic kidney disease. Clinicians and health care systems must be encouraged to make use of these treatments.”

Kidney Disease 52

Kidney Disease Outcomes Diabetes Heart Failure 52

DAIC

APRIL 6, 2024

As evidence has mounted pointing to their benefits in reducing heart failure and other forms of heart disease, researchers have sought to determine whether these drugs could help to prevent heart failure even in people without diabetes or chronic kidney disease. Researchers tracked outcomes for a median of just under 18 months.

Heart attacks 81

Heart attacks Heart Attack Heart Failure Outcomes 81

DAIC

APRIL 6, 2024

As evidence has mounted pointing to their benefits in reducing heart failure and other forms of heart disease, researchers have sought to determine whether these drugs could help to prevent heart failure even in people without diabetes or chronic kidney disease. Researchers tracked outcomes for a median of just under 18 months.

Heart attacks 98

Heart attacks Heart Attack Heart Failure Outpatient 98